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Purpose: Late diagnosis and treatment lead to high mortality and poor prognosis 
in tuberculous meningitis (TbM). A rapid and accurate diagnosis is necessary for a 
good prognosis. Neuron-specific enolase (NSE) has been investigated as a bio-
chemical marker of nervous tissue damage. In the present study, the usefulness of 
NSE was evaluated, and a cut-off value for the differential diagnosis of TbM was 
proposed. Materials and Methods: Patient charts were reviewed for levels of se-
rum and cerebrospinal fluid (CSF) NSE, obtained from a diagnostic CSF study of 
samples in age- and gender-matched TbM (n=15), aseptic meningitis (n=28) and 
control (n=37) patients. Results: CSF/serum NSE ratio was higher in the TbM 
group than those of the control and aseptic groups (p=0.001). In binary logistic re-
gression, CSF white blood cell count and CSF/serum NSE ratio were significant 
factors for diagnosis of TbM. When the cut-off value of the CSF/serum NSE ratio 
was 1.21, the sensitivity was 86.7% and the specificity was 75.4%. Conclusion: 
The CSF/serum NSE ratio could be a useful parameter for the early diagnosis of 
TbM. In addition, the authors of the present study suggest a cut-off value of 1.21 
for CSF/serum NSE ratio.
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INTRODUCTION
The diagnosis of tuberculous meningitis (TbM) is difficult because early symptoms 
and laboratory results from cerebrospinal fluid (CSF) are unspecific to tuberculosis 
and overlap with those of other chronic diseases of the central nervous system. Late 
diagnosis can result in a poor prognosis and even death, and a confirmative culture 
study for TbM requires a long time before a diagnosis can be affirmatively made. 
Rapid diagnosis and proper treatment is essential for TbM and a lack of confi-
dence in test results can delay the initiation of treatment with anti-tuberculosis 
medication in TbM patients.1,2 In addition, most of the tests developed for the early 
diagnosis of TbM are not sensitive3 and cannot be used routinely.4,5 
Neuron-specific enolase (NSE) is found in relatively large amounts in neurons, 
peripheral nervous system tissues and neuroendocrine cells, and is, therefore, one 
of the most often investigated biochemical markers of nervous tissue damage. In-
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generative disease, autoimmune disease or traumatic brain 
damage were excluded because these conditions can increase 
serum and CSF NSE levels. 
Serum NSE collection and quantification 
All patient samples of NSE were collected intravenously 
upon admission. Samples were centrifuged for 30 minutes 
and stored at -80°C for later analysis. The NSE sample was 
analyzed using an enzyme immunoassay based on the sand-
wich technique including the solid-phase monoclonal anti-
body against NSE (Cobas Core II; Roche Diagnostics, Basel, 
Switzerland). Hemolytic specimens were excluded because 
blood cell lysis influences serum NSE level.12
Data analysis
Statistical analysis was performed with PASW Statistics 
software, version 18 (IBM, Chicago, IL, USA). To compare 
variables among the TbM, aseptic meningitis and controls 
groups, chi-square, one-way ANOVA and Scheffe’s post-
hoc analyses were used. A p-value of less than 0.05 was 
considered significant. 
To investigate predictive factors for diagnosis of TbM, 
binary logistic regression was performed, where variables 
with a p-value of less than 0.1 in univariate analysis were 
entered into the multivariate analysis. To analyze the sensi-
tivity, specificity and cut-off value of CSF/serum NSE ra-
tio, NSE related variables significant in multivariate logistic 
regression were used to generate receiver operating charac-
teristic (ROC) curves. A two-tailed value of p<0.05 was 
considered significant. 
 
RESULTS
 
The demographic features and laboratory findings of the pa-
tient and control groups are presented in Table 1. There were 
no significant differences in demographic features among 
the three groups (Table 1). Fifteen patients were included in 
the TbM group, 28 in the aseptic meningitis group and 37 in 
the control group. The TbM group consisted of 3 patients 
with confirmed TbM via culture, one that was smear-posi-
tive and 11 presumptive (two patients showed dramatic re-
sponsiveness to anti-tuberculosis medication; one patient’s 
chest radiography was consistent with active pulmonary tu-
berculosis; eight patients exhibited typical brain imaging 
findings for TbM). There were no seizures or altered mental 
states in TbM group and 8 patients showed basal meningeal 
creased NSE levels in serum, CSF, or both have been report-
ed in several neurological diseases, including status epilepti-
cus,6 Creutzfeldt-Jakob disease,7 acute ischemic stroke,8 
head injury9 and hypoxic brain injury.10 NSE can also act as a 
marker of neuronal damage, especially in meningitis;11 how-
ever, data for TbM is rare. The authors of the present study 
attempted to confirm the usefulness of NSE and to propose a 
cut-off value for the differential diagnosis of TbM.
MATERIALS AND METHODS
　　　
Patients
The authors retrospectively reviewed charts from January 
2000 to June 2008 to determine the levels of serum and CSF 
NSE obtained before starting anti-Tb or anti-viral treatment. 
We investigated NSE routinely for evaluating central ner-
vous system involvement. The TbM groups were subdivided 
into a group of patients in whom M. tuberculosis was ob-
served by direct smear with acid fast bacillus staining or in 
CSF culture (confirmative TbM) or a group of patients with 
CSF findings of pleocytosis with lymphocytic predomi-
nance, decreased CSF (blood glucose ratio less than 0.5), ele-
vated protein, negative gram and India ink stains, no positive 
bacterial or fungal cultures, and one or more of the follow-
ing: dramatic responsiveness to anti-tuberculosis medication 
that subsided neurologic symptoms, i.e. improvement in 
headache, fever, ocular movement and CSF findings; chest 
radiography consistent with active pulmonary tuberculosis or 
confirmed in another organ; typical brain CT or brain MRI 
findings such as hydrocephalus; edema; or basal meningeal 
enhancement (presumptive TbM). The age and sex matched 
control group included tension type headache patients diag-
nosed with normal neurological examination, brain imaging 
and CSF results. Lumbar puncture was performed in patients 
with meningitis-like symptoms with posterior neck pain or 
neck stiffness, even though tension type headaches were sus-
pected. The aseptic meningitis group included patients who 
had acute onset of fever, symptoms and signs of meningeal 
irritation and supportive CSF findings such as a mild increase 
in protein, normal glucose level and predominantly lympho-
cytic pleocytosis, no history or clinical findings of intra or ex-
tra-cranial tuberculosis, no seizure and alteration of con-
sciousness, no organismal growth in a culture study and 
conversion to normal CSF upon follow up CSF test at 3 days 
after the first lumbar puncture. Patients with fungal and bac-
terial meningitis, stroke, seizure, meningoencephalitis, de-
Tae-Jin Song, et al.
Yonsei Med J   http://www.eymj.org   Volume 53   Number 6   November 20121070
groups, and there were no differences in laboratory findings 
between the two groups (confirmative and presumptive 
groups) by Mann-Whitney U test. Moreover, in one-Way 
ANOVA and Kruskal-Wallis test, CSF WBC count, CSF 
glucose level, CSF protein level, CSF NSE/serum NSE ra-
tio, and CSF glucose/serum glucose ration were significant-
ly different among the control, aseptic and confirmative 
TbM group, as well as among the control, aseptic and pre-
sumptive group. In univariate logistic regression, higher 
CSF WBC count (p=0.001), lower CSF glucose (p=0.001), 
higher CSF/serum NSE ratio (p=0.001) and lower CSF/se-
rum glucose ratio (p=0.001) were significant factors for di-
agnosis of TbM. In multivariate logistic regression, CSF 
WBC count (p=0.004) and CSF/serum NSE ratio (p=0.022) 
were significant prognostic factors for diagnosis of TbM 
(Table 2). In ROC curve, when the cut-off value of the CSF/
serum NSE ratio was 1.21, the sensitivity was 86.7% and 
the specificity was 75.4%.
enhancement, 3 patients showed cerebral edema, and one 
patient showed hydrocephalus. There were significant dif-
ferences in CSF white blood cell (WBC) count, CSF glu-
cose level, CSF protein level, CSF glucose/serum glucose 
ratio and CSF/serum NSE ratio (p=0.001) among the three 
groups.  
On the Scheffe’s post-hoc analysis, CSF WBC count was 
higher in the TbM group than in the aseptic (p=0.002) and 
control groups (p=0.001); CSF glucose was lower in the 
TbM group than in the aseptic (p=0.001) and control 
groups (p=0.001); CSF protein was higher in the TbM 
group than in the aseptic (p=0.001) and control groups 
(p=0.001); CSF/serum NSE ratio was higher in the TbM 
group than in the aseptic (p=0.001) and control groups 
(p=0.001); and CSF/serum glucose ratio was lower in the 
TbM group than in the aseptic (p=0.001) and control 
groups (p=0.001). We performed subgroup analysis divid-
ing the TbM group into confirmative and presumptive 
Table 1. Demographic Features and Laboratory Findings
Control 
(n=37)
Tb meningitis 
(n=15)
Aseptic meningitis 
(n=28)
p value
Age (yrs)   39.29±16.54   41.13±15.24   43.28±13.31 0.582
Male, n (%) 16 (43.2) 6 (40.0) 12 (42.9) 0.976
CSF WBC (count)   0.85±1.03      328.33±194.67*‡    100.93±122.02† 0.001
CSF glucose (mg/dL)   65.59±12.89      45.53±12.25*‡   62.21±10.64 0.001
Serum glucose (mg/dL)   93.73±10.66   96.67±10.51 96.36±9.90 0.502
CSF protein (mg/dL) 29.39±7.12    243.00±99.87*‡    68.43±28.75† 0.001
CSF NSE (ng/dL)   9.46±5.76 12.35±3.52   9.79±6.10 0.225
Serum NSE (ng/dL) 10.42±6.06   8.00±2.17   9.57±7.16 0.874
CSF/serum NSE ratio   0.92±0.30      1.62±0.59*‡   1.07±0.23 0.001
CSF/serum glucose ratio   0.68±0.09      0.47±0.12*‡   0.65±0.13 0.001
SD, standard deviation; WBC, white blood cell; NSE, neuron specific enolase; CSF, cerebrospinal fluid; Tb, tuberculosis. 
*p<0.05 (control versus Tb meningitis).
†p<0.05 (control versus aseptic meningitis).
‡p<0.05 (Tb meningitis versus aseptic meningitis).
Table 2. The Results of Univariate and Multivariate Logistic Regression for Tuberculosis Meningitis Diagnosis
Variable
Univariate Multivariate
Odds ratio p value Odds ratio p value
Sex   1.135 0.828
Age   1.001 0.978
CSF WBC   1.011 0.001   1.012 0.004
CSF glucose   0.869 0.001   1.035 0.725
Serum glucose   0.541 1.017
CSF protein 78.770 0.970
CSF NSE   1.076 0.102
Serum NSE   0.873 0.272
CSF/Serum NSE ratio 91.504 0.001 51.418 0.022
CSF/Serum glucose ratio   0.231 0.001 0.01 0.204
CSF, cerebrospinal fluid; WBC, white blood cell; NSE, neuron specific enolase.
Mean±SD, n (%) 
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Although immunoassays based on CSF antigen-antibody re-
actions, including enzyme-linked immunosorbent assay 
(ELISA), have been reported with variable sensitivities and 
specificities16,17,23 these diagnostic methods cannot be readily 
used just anywhere. CSF adenosine deaminase activity 
(ADA) has been studied for diagnosis of TbM.24,25 CSF 
ADA has shown a relatively high validity, with a sensitivity 
ranging from 44% to 100% and a specificity of 75% to 99%. 
However, previous study that showed a highly reliable result 
with a sensitivity of 100% and specificity of 99% in only 
three cases.24 In addition, CSF culture for TbM requires two 
months to produce results. Overall, radioactive bromide 
partition test,15 immunoassay,16 latex particle agglutina-
tion,17 PCR, ADA and ELISA are not always accessible, 
and their reliabilities have not been thoroughly investigated.
In the present study, the sensitivity and specificity for 
CSF/serum NSE ratio were comparable with those of pre-
vious studies, especially the results of PCR, ELISA or ADA 
tests.15-18,23-25 Moreover, CSF and serum NSE results can be 
acquired more quickly and simply.
There are limitations in our study. First, our results showed 
a relatively low sensitivity and specificity for diagnosis of 
TbM. Neuron-Specific enolase estimation can non-specifi-
cally be raised in any brain disorder. Second, other chronic 
meningitis and partially treated bacterial meningitis cannot 
be differentiated by NSE, even though we excluded menin-
gitis patients who showed suspected bacterial or other men-
ingitis on clinical, laboratory and brain image findings. 
Third, the small sample size is an important limitation of 
our study. With only 15 cases in the disease group, the sta-
tistical reliability is weak.
In conclusion, CSF/serum NSE ratio could be a useful pa-
rameter for the early diagnosis of TbM. In addition, the au-
thors of the present study suggest a cut-off value of 1.21 for 
CSF/serum NSE ratio. However, because the sensitivity and 
specificity were not high, clinical correlation and brain im-
age study have to be considered for the diagnosis of TbM.
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